November 1st GPRA Expansion Launch

As a reminder, we are expecting most CSBs to begin expanding the GPRA to additional SOR-supported populations starting this week, as it is the first week of November. This is with exception to the CSBs who have talked to us about needing a longer roll-out period for GPRA expansion.

Thank you to everyone who has taken the time to speak to us over the phone about their CSB and GPRA process. We have truly enjoyed the opportunity to get to know you all and to learn about all of the unique services and programs you offer.

Good luck to everyone on expanding the GPRA. We are excited to get more representation from all CSBs through the GPRA and to move closer to the grant’s state-wide GPRA goal. Please do not hesitate to reach out with any questions or concerns regarding GPRA expansion.

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.